248 related articles for article (PubMed ID: 24664623)
21. The sentinel node in breast cancer--a multicenter validation study.
Krag D; Weaver D; Ashikaga T; Moffat F; Klimberg VS; Shriver C; Feldman S; Kusminsky R; Gadd M; Kuhn J; Harlow S; Beitsch P
N Engl J Med; 1998 Oct; 339(14):941-6. PubMed ID: 9753708
[TBL] [Abstract][Full Text] [Related]
22. Detection of infraclavicular lymph node metastases using ultrasonography in breast cancer.
Altinyollar H; Dingil G; Berberoglu U
J Surg Oncol; 2005 Dec; 92(4):299-303. PubMed ID: 16299805
[TBL] [Abstract][Full Text] [Related]
23. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
24. Preoperative FDG-PET for axillary metastases in patients with breast cancer.
Chung A; Liou D; Karlan S; Waxman A; Fujimoto K; Hagiike M; Phillips EH
Arch Surg; 2006 Aug; 141(8):783-8; discussion 788-9. PubMed ID: 16924086
[TBL] [Abstract][Full Text] [Related]
25. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
[TBL] [Abstract][Full Text] [Related]
26. Nomograms for preoperative prediction of axillary nodal status in breast cancer.
Dihge L; Bendahl PO; Rydén L
Br J Surg; 2017 Oct; 104(11):1494-1505. PubMed ID: 28718896
[TBL] [Abstract][Full Text] [Related]
27. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma.
Topps A; Clay V; Absar M; Howe M; Lim Y; Johnson R; Bundred N
Eur J Surg Oncol; 2014 Jul; 40(7):813-7. PubMed ID: 24797703
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer patients with pN0(i+) and pN1(mi) sentinel nodes have high rate of nonsentinel node metastases.
Menes TS; Tartter PI; Mizrachi H; Constantino J; Estabrook A; Smith SR
J Am Coll Surg; 2005 Mar; 200(3):323-7. PubMed ID: 15737841
[TBL] [Abstract][Full Text] [Related]
29. Cross-validation of three predictive tools for non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node.
Tvedskov TF; Meretoja TJ; Jensen MB; Leidenius M; Kroman N
Eur J Surg Oncol; 2014 Apr; 40(4):435-41. PubMed ID: 24534362
[TBL] [Abstract][Full Text] [Related]
30. Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer.
Jackson RS; Mylander C; Rosman M; Andrade R; Sawyer K; Sanders T; Tafra L
Ann Surg Oncol; 2015 Oct; 22(10):3289-95. PubMed ID: 26224404
[TBL] [Abstract][Full Text] [Related]
31. Comparison between Ultrasound and Pathologic Status of Axillary Lymph Nodes in Clinically Node-negative Breast Cancer Patients.
Bailey A; Layne G; Shahan C; Zhang J; Wen S; Radis S; Richmond B; Partin J; Hazard H
Am Surg; 2015 Sep; 81(9):865-9. PubMed ID: 26350662
[TBL] [Abstract][Full Text] [Related]
32. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node mapping for staging breast cancer: preliminary results of a prospective study.
Rehman S; Sardi A; Spiegler E; Colandrea J; Frishberg D
Md Med J; 1999; 48(3):105-10. PubMed ID: 10394225
[TBL] [Abstract][Full Text] [Related]
34. Use of axillary ultrasonography in breast cancer: a useful tool to reduce sentinel node procedures.
Sianesi M; Ceci G; Ghirarduzzi A; Del Rio P; Guazzi A; Pisanelli B; Martella E; Ardizzoni A; Di Blasio B; Arcuri MF
Ann Ital Chir; 2009; 80(4):315-8. PubMed ID: 19967892
[TBL] [Abstract][Full Text] [Related]
35. Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.
Agresti R; Crippa F; Sandri M; Martelli G; Tagliabue E; Alessi A; Pellitteri C; Maccauro M; Maugeri I; Barbara P; Rampa M; Moscaroli A; Ferraris C; Carcangiu ML; Bianchi G; Greco M; Bombardieri E
Breast; 2014 Aug; 23(4):334-40. PubMed ID: 24485802
[TBL] [Abstract][Full Text] [Related]
36. Accurate staging with internal mammary chain sentinel node biopsy for breast cancer.
Gnerlich JL; Barreto-Andrade JC; Czechura T; John JR; Turk MA; Kennedy TJ; Winchester DJ
Ann Surg Oncol; 2014 Feb; 21(2):368-74. PubMed ID: 24046119
[TBL] [Abstract][Full Text] [Related]
37. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
[TBL] [Abstract][Full Text] [Related]
38. Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients?
Unal B; Gur AS; Ahrendt G; Johnson R; Bonaventura M; Soran A
Clin Breast Cancer; 2009 May; 9(2):92-5. PubMed ID: 19433389
[TBL] [Abstract][Full Text] [Related]
39. Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients.
van Nijnatten TJA; Ploumen EH; Schipper RJ; Goorts B; Andriessen EH; Vanwetswinkel S; Schavemaker M; Nelemans P; de Vries B; Beets-Tan RGH; Smidt ML; Lobbes MBI
Eur J Radiol; 2016 Dec; 85(12):2288-2294. PubMed ID: 27842679
[TBL] [Abstract][Full Text] [Related]
40. Preoperative dynamic lymphoscintigraphy predicts sentinel lymph node metastasis in patients with early breast cancer.
Nakashima K; Kurebayashi J; Sonoo H; Tanaka K; Ikeda M; Shiiki S; Yamamoto Y; Nomura T; Sohda M; Seki M; Miyake A; Moriya T; Sadahira Y; Mimura H; Fukunaga M
Breast Cancer; 2010; 17(1):17-21. PubMed ID: 19466508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
